Post-traumatic stress disorder (PTSD) is a mental health condition triggered by experiencing or witnessing a traumatic event. It is characterized by symptoms such as intrusive memories, nightmares, flashbacks, hyperarousal, and avoidant behavior. As of the latest studies, PTSD is estimated to affect approximately 7-8% of the population during their lifetime, with higher rates among military veterans, survivors of violence, and individuals exposed to natural disasters.

With the increasing recognition of the potential therapeutic effects of cannabis, there has been significant interest in exploring its role in treating PTSD. Cannabis contains more than 100 different cannabinoids, the most well-known being tetrahydrocannabinol (THC) and cannabidiol (CBD). While THC is primarily associated with the psychoactive effects of marijuana, CBD is non-psychoactive and is thought to offer a range of therapeutic benefits.

The endocannabinoid system (ECS) plays a crucial role in regulating various physiological processes, including mood, stress response, pain perception, and memory. The ECS consists of two main types of receptors: CB1 receptors, predominantly found in the brain, and CB2 receptors, which are located in the peripheral tissues and immune system. When cannabis is consumed, the cannabinoids interact with these receptors to modulate brain functions and bodily systems.

How Marijuana May Help with PTSD

Research indicates that marijuana may influence several key aspects of PTSD through different mechanisms:

Memory Extinction

One of the core mechanisms in PTSD involves the difficulty in extinguishing traumatic memories. THC, the main psychoactive compound in cannabis, has been shown to potentially enhance the extinction of fear-related memories. Studies suggest that THC could modify the amygdala’s activity, an area of the brain responsible for processing emotions and fear.

THC: May reduce nightmares and improve sleep at low doses, but high doses can sometimes increase anxiety.

Reduction in Hyperarousal

Those suffering from PTSD often experience hyperarousal, which manifests as anxiety, insomnia, and irritability. Both THC and CBD have been reported to reduce symptoms of anxiety, making them potential candidates for alleviating hyperarousal. THC and CBN’s sedative effects might help with sleep disturbances, while CBD may reduce overall stress levels. Balanced THC:CBD combinations can offer symptom relief while reducing unwanted side effects.

CBN (Cannabinol): CBN is created when THC degrades over time with exposure to heat, light, and oxygen. CBN is mildly psychoactive but far less potent than THC. It can cause mild intoxication in large doses and is most often used for its sedative properties to promote sleep.

CBD (Cannabidiol): CBD is non-intoxicating and may help reduce anxiety, improve emotional balance, and support better sleep.

Inflammation and Neuroprotection

PTSD has been linked with chronic inflammation and alterations in brain structure. CBD has anti-inflammatory and neuroprotective properties, which could theoretically help reduce the neurobiological consequences of prolonged PTSD.

CBG (Cannabigerol): CBG is a non-psychoactive cannabinoid found in small amounts in the cannabis plant. It is a precursor to other cannabinoids, such as CBD and THC. CBG may help with pain relief, neuroprotection, anxiety relief, and improved mood and overall well-being.

Recommended Strains and Terpenes

Certain strains and terpenes may be better suited for PTSD symptom relief, especially those that promote calmness, relaxation, and emotional balance.

Beneficial Terpenes:

  • Linalool: Floral aroma; known for its calming, anti-anxiety effects
  • Myrcene: Found in hops and mangoes; promotes relaxation and better sleep
  • Caryophyllene: Found in pepper; may help reduce stress and inflammation
  • Limonene: Citrus aroma; known for antidepressant and anti-anxiety properties

High-CBD or Balanced Strains: Can calm anxiety and promote relaxation.

DeeDee Recommends:

THC Products: The products below are high in the following terpenes: Caryophyllene, Limonene, Linalool, and Myrcene:

  • 22 Lemons Flower [3.5g] (INSA)
  • Dulce de Uva Cartridge [1g] (Rythm)

THC:CBD Products (1:1 Ratio)

  • 1:1 CBD:THC [15ml] (330mg) (Standard Farms)
  • 1:1 [30ml] (150mg CBD/150mg THC) (&Shine)
  • Clear 1:1 CBD:THC – Peach [100ml] (100mg CBD/100mg THC) (PHG)

THC:CBN Products (for Sleep)

  • Pomegranate R&R 1:1 CBN:THC [20pk] (100mg CBN/100mg THC) (Verano)
  • 1:1 Tranquility [20pk] (10mg THC/10mg CBN per capsule) (Organic Remedies)

CBD:THC Products (2:1 Ratio)

  • 2:1 Strawberry Peach [10pk] (200mg CBD/100mg THC) (Verano)

THC:CBG Products

  • Yuzu Zone 1:1 CBG:THC [20pk] (100mg CBG/100mg THC) (Verano)

Current Research and Evidence

The research investigating the efficacy of marijuana and its components in treating PTSD is growing, although the results remain mixed. While animal studies and early human trials show promising outcomes, there is still a lack of large-scale, randomized controlled trials (RCTs) to definitively confirm clinical effectiveness.

Cannabinoid-Specific Research

THC: Some studies suggest that THC’s ability to suppress fear and anxiety might make it a promising treatment for PTSD. For instance, research indicates that THC can potentially disrupt traumatic memory reconsolidation, which may help individuals “unlearn” the intense fear responses associated with the trauma. However, high doses of THC may lead to exacerbated anxiety or paranoia, especially in individuals who are predisposed to such reactions.

CBD: Unlike THC, CBD is generally non-psychoactive and does not produce a “high.” Studies have shown that CBD may alleviate anxiety, improve sleep, and act as an anti-inflammatory. A 2021 trial published in Cannabis and Cannabinoid Research found that CBD significantly reduced PTSD symptoms in participants, especially related to anxiety and sleep disturbances. CBD has also been investigated for its potential to support neural plasticity and reduce trauma-induced changes in the brain.

Veterans and PTSD

Veterans represent a significant portion of individuals suffering from PTSD, and their experience has spurred much of the research into cannabis as a potential treatment. While the Department of Veterans Affairs (VA) has not approved cannabis as a treatment for PTSD, Pennsylvania does list PTSD as one of the qualifying conditions for participation in the state’s medical marijuana program.

Anecdotal evidence and patient reports suggest that marijuana has helped many veterans manage their symptoms, particularly with regard to sleep and anxiety. And as a former pharmacist for the VA, I strongly believe that many of our veterans could benefit from the use of medical marijuana adjacent to current therapies.

Conclusion

The use of marijuana, particularly its components THC and CBD, as a treatment for PTSD represents an exciting area of research. While preliminary evidence suggests that cannabis may offer significant symptom relief, especially for anxiety, insomnia, and hyperarousal, more rigorous clinical trials are needed to substantiate these claims. The risks associated with marijuana use, particularly its potential for dependence and psychiatric side effects, should be carefully considered by both healthcare providers and patients.

This information is for educational purposes only and is not medical advice. Always consult with qualified healthcare providers before starting any new treatment, including cannabis products.